Menu
Search
|

Menu

Close
X

Medpace Holdings Inc MEDP.OQ (NASDAQ Stock Exchange Global Select Market)

85.65 USD
+3.73 (+4.55%)
As of Sep 13
Previous Close 81.92
Open 82.11
Volume 174,187
3m Avg Volume 144,835
Today’s High 85.96
Today’s Low 82.03
52 Week High 85.96
52 Week Low 45.89
Shares Outstanding (mil) 35.82
Market Capitalization (mil) 2,424.22
Forward P/E 32.43
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.14 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY19
201
FY18
705
FY17
436
FY16
422
EPS (USD)
FY19
0.513
FY18
1.971
FY17
0.910
FY16
0.345
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
32.43
33.85
Price to Sales (TTM)
vs sector
3.27
7.90
Price to Book (MRQ)
vs sector
3.89
4.38
Price to Cash Flow (TTM)
vs sector
21.14
23.70
Total Debt to Equity (MRQ)
vs sector
8.97
17.64
LT Debt to Equity (MRQ)
vs sector
8.97
12.61
Return on Investment (TTM)
vs sector
10.49
12.69
Return on Equity (TTM)
vs sector
13.67
17.13

EXECUTIVE LEADERSHIP

Jesse Geiger
Chief Financial Officer, Chief Operating Officer - Laboratory Operations, Since
Salary: $378,000.00
Bonus: $100,000.00
Susan Burwig
Executive Vice President - Operations, Since 2017
Salary: $394,599.00
Bonus: $79,150.00
Stephen Ewald
General Counsel, Corporate Secretary, Since
Salary: --
Bonus: --
Fred Davenport
Director, Since 2018
Salary: --
Bonus: --
Ashley Keating
Director, Since 2019
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

5375 Medpace Way
CINCINNATI   OH   45227-1543

Phone: +1513.5799911

Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

SPONSORED STORIES